Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.11
Delayed Data
As of Jul 31
 +0.06 / +0.99%
Today’s Change
3.33
Today|||52-Week Range
6.85
+46.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues23.2M25.0M23.0M24.4M
 
 
 
 
 
Cost of Goods Sold11.4M12.1M11.9M13.6M
 
 
 
 
 
Depreciation And Amortization1.6M1.5M1.7M--
 
 
 
 
 
Operating ExpensesGross Income10.2M11.4M9.5M10.8M
 
 
 
 
 
General Expenses9.9M10.1M10.0M10.8M
 
 
 
 
 
Research And Development925.0K319.0K613.0K803.0K
 
 
 
 
 
Total Operating Expenses22.9M23.7M23.6M24.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income288.0K1.3M-561.0K28.0K
 
 
 
 
 
Extraordinary Charge-361.0K0.00----
 
 
Interest Expense On Debt218.0K193.0K195.0K189.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-291.0K1.1M-756.0K-161.0K
 
 
 
 
 
Income Taxes0.00-79.0K-5.0K-15.0K
 
 
 
 
Net Income-291.0K1.0M-761.0K-176.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.4M60.0M60.3M60.4M
 
 
 
 
 
Shares To Calculate EPS Diluted54.4M62.7M60.3M60.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01$0.02-$0.01$0.00
 
 
 
 
EPS Diluted-$0.01$0.02-$0.01-$0.00